These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32984826)

  • 1. Vasopressor-Refractory Shock From Clozapine Overdose Treated With Synthetic Angiotensin II Infusion.
    Wieruszewski PM; Nelson S; Wittwer ED; Leung JG
    Crit Care Explor; 2020 Sep; 2(9):e0185. PubMed ID: 32984826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
    Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
    J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
    [No Abstract]   [Full Text] [Related]  

  • 4. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
    Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW; Kroll S; Greenfeld CR; Hodges T; Chow JH;
    Crit Care; 2023 May; 27(1):175. PubMed ID: 37147690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients.
    Bailey DM; Chima RS; Tidmarsh GF; Williams MD
    Crit Care Explor; 2019 Aug; 1(8):e0036. PubMed ID: 32166277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Agents for the Treatment of Vasodilatory Shock.
    Knotzer H; Poidinger B; Kleinsasser A
    Curr Pharm Des; 2019; 25(19):2133-2139. PubMed ID: 31272348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
    Chen A; Wong A
    J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Observational Cohort Study of Angiotensin II in Shock.
    Smith SE; Newsome AS; Guo Y; Hecht J; McCurdy MT; Mazzeffi MA; Chow JH; Kethireddy S
    J Intensive Care Med; 2022 Jan; 37(1):75-82. PubMed ID: 33231111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Treatment of Antihypertensive Overdose Using Intravenous Angiotensin II.
    Carpenter JE; Murray BP; Saghafi R; Thomas B; Lee S; Kleiman R; Punja M; Silver E; Busse LW
    J Emerg Med; 2019 Sep; 57(3):339-344. PubMed ID: 31279637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of angiotensin II as vasopressor in vasodilatory shock.
    Lumlertgul N; Ostermann M
    Future Cardiol; 2020 Nov; 16(6):569-583. PubMed ID: 32462921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review.
    Semedi BP; Rehatta NM; Soetjipto S; Nugraha J; Mahyuddin MH; Arnindita JN; Wairooy NAP
    Open Access Emerg Med; 2023; 15():1-11. PubMed ID: 36636460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II Use in Refractory Multisystem Shock: A Case Report.
    Ahmed M; Habis S; Mahmoud A; Rutland C; Saeed R
    Cureus; 2018 Nov; 10(11):e3665. PubMed ID: 30740284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressors in septic shock: which, when, and how much?
    Shi R; Hamzaoui O; De Vita N; Monnet X; Teboul JL
    Ann Transl Med; 2020 Jun; 8(12):794. PubMed ID: 32647719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.